Biogen joins CTTV
Lab Matters Pioneering target validation collaboration expands to accelerate drug discovery research.
2016
lab-matters
Target Validation platform launches
Lab Matters Identifying evidence-based relationships between drug targets and diseases.
2015
lab-matters
Jeffrey Barrett to lead CTTV
Lab Matters Jeffrey Barrett appointed Director of CTTV, the GSK, EMBL-EBI and Sanger Institute partnership.
2015
lab-matters
On target
Lab Matters A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
2014
lab-matters
Where do you start when developing a new medicine?
Lab Matters A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for…
2014
lab-matters
No matching posts found
